US Map / Massachusetts
State MA

Clinical Trials in Massachusetts

Massachusetts is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Massachusetts and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 474 actively recruiting studies with Massachusetts sites out of 474 registered in total. The busiest research areas in Massachusetts are Prostate Cancer, Colorectal Cancer, Breast Cancer. Leading sponsors running trials in the state include Massachusetts General Hospital, Brigham and Women's Hospital, Boston Children's Hospital. By stage, Massachusetts trials break down as Phase 1 (86), Phase 2 (125), Phase 3 (78), Phase 4 (14).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
474
Recruiting Now
474
← Back to US Map
Top Conditions in Massachusetts
Prostate Cancer (8)Colorectal Cancer (7)Breast Cancer (7)Cancer (6)Solid Tumor (6)Heart Failure (6)Lung Cancer (6)Advanced Solid Tumors (6)Multiple Myeloma (6)Schizophrenia (5)Acute Myeloid Leukemia (5)Healthy (5)

Frequently Asked Questions — Clinical Trials in Massachusetts

How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 474 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 474. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Colorectal Cancer, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Massachusetts

NCT06425926 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Condition
Melanoma Stage IV
Enrollment
117 pts
Location
United States
Sponsor
Georgiamune Inc
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT03217006 N/A
Recruiting
Randomization of Single vs Multiple Arterial Grafts
Condition
Coronary Artery Disease
Enrollment
4,300 pts
Location
United States, Austria, Brazil
Sponsor
Weill Medical College of Corne
View Trial →
NCT06430385 Phase 1, Phase 2
Recruiting
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Phar...
Condition
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Enrollment
48 pts
Location
United States, Austria, Canada
Sponsor
Ionis Pharmaceuticals, Inc.
View Trial →
NCT05715684 N/A
Recruiting
Patient-Centered Surgical Prehabilitation
Condition
Bladder Cancer
Enrollment
25 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT07637994 N/A
Recruiting
Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to I...
Condition
Opioid Abuse (Disorder)
Enrollment
100 pts
Location
United States
Sponsor
University of Massachusetts, W
View Trial →
NCT05137054 Phase 1
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination Wit...
Condition
Multiple Myeloma
Enrollment
317 pts
Location
United States, France, Greece
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07549698 Phase 1, Phase 2
Recruiting
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Re...
Condition
Warm Autoimmune Hemolytic Anemia (WAIHA)
Enrollment
60 pts
Location
United States, Germany, Spain
Sponsor
CRISPR Therapeutics AG
View Trial →
NCT06987877 N/A
Recruiting
Efficacy of Routine Saline Flushing in the Prevention of Nephrostomy Tube Obstru...
Condition
Nephrostomy
Enrollment
20 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT05911568 N/A
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disab...
Condition
Stroke
Enrollment
1,060 pts
Location
United States
Sponsor
University of Cincinnati
View Trial →
NCT06910969 N/A
Recruiting
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Condition
Bone Marrow Transplant Complications
Enrollment
350 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06957366 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patien...
Condition
Atrial Fibrillation (AF)
Enrollment
920 pts
Location
United States, Belgium, Canada
Sponsor
McMaster University
View Trial →
NCT06453694 Phase 2
Recruiting
Efgartigimod for the Treatment of Acute Optic Neuritis
Condition
Optic Neuritis
Enrollment
20 pts
Location
United States
Sponsor
Anastasia Vishnevetsky, MD, MP
View Trial →
NCT07762066 N/A
Recruiting
Bridge to Belonging: Peer Led Intervention to Reduce Loneliness and Depression A...
Condition
HIV
Enrollment
40 pts
Location
United States
Sponsor
Fenway Community Health
View Trial →
NCT06083922 Phase 2
Recruiting
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab...
Condition
Multiple Myeloma
Enrollment
20 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT04794322 N/A
Recruiting
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Condition
Ovarian Neoplasms
Enrollment
250 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT03922555 Phase 1
Recruiting
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Condition
Neurological Cancer
Enrollment
18 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07630974 Phase 1, Phase 2
Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
134 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05825820 N/A
Recruiting
Pilot Study of Health System/Community Partnership for Enhanced Outreach to Prev...
Condition
Suicide
Enrollment
20 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT03686124 Phase 1, Phase 2
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in R...
Condition
Refractory Cancer
Enrollment
375 pts
Location
United States, Germany
Sponsor
Immatics US, Inc.
View Trial →
NCT06563596 Phase 2
Recruiting
Epco, Zanu, Ritux for R/R FL or MZL
Condition
Follicular Lymphoma
Enrollment
71 pts
Location
United States
Sponsor
Reid Merryman, MD
View Trial →
NCT06289010 N/A
Recruiting
Neural Mechanisms of Family-Focused Treatment for Youth Depression
Condition
Childhood Depression
Enrollment
80 pts
Location
United States
Sponsor
Boston University Charles Rive
View Trial →
NCT06221852 N/A
Recruiting
Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
Condition
Bipolar I Disorder
Enrollment
50 pts
Location
United States
Sponsor
Mclean Hospital
View Trial →
NCT06598189 N/A
Recruiting
Ear-Seizure Detection (EarSD) Study
Condition
Seizures
Enrollment
40 pts
Location
United States
Sponsor
Felicia Chu
View Trial →
Page 7 of 19 — 474 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology